Vaccination Coverage and Level of Protection in Patients at Risk
NCT03820752 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2179
Last updated 2020-10-23
Summary
The purpose of this study is to determine
1. vaccination coverage of recommended vaccines (routine childhood vaccines and vaccines against seasonal flu and pneumococci) in children with chronic diseases (allergy, cystic fibrosis, diabetes mellitus type 1, congenital heart disease, immunocompromised and solid organ transplant patients)
2. the level of protection against measles, mumps, rubella and pertussis in children with chronic diseases.
3. vaccination coverage of recommended vaccines (diphtheria, tetanus, pertussis and vaccines against seasonal flu and pneumococci) in adults with chronic diseases (nephropathy, diabetes mellitus, COPD, heart failure, HIV and solid organ transplant patients)
4. the level of protection against diphtheria, tetanus and pertussis in adults with chronic diseases.
Conditions
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Corinne Vandermeulen, MD, PhD · KU Leuven
Eligibility
- Min Age
- 2 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2017-06-30
- Completion
- 2020-08-30
Countries
- Belgium
Study Locations
More Related Trials
-
Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults
NCT00197821 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.
NCT00327522 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults
NCT00744263 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Pneumococcal Vaccine Coverage
NCT03597269 ·Status: COMPLETED
-
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
NCT07348692 ·Status: RECRUITING ·Phase: PHASE3
-
Synchronized Immunization NotifiCations
NCT02710318 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years
NCT00761631 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age
NCT03313050 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans
NCT06271681 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)
NCT00560950 ·Status: COMPLETED ·Phase: PHASE3
-
Surveillance of Invasive Pneumococcal Infections in Adults (Excluding Meningitis)
NCT03983616 ·Status: UNKNOWN
-
Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents
NCT06838000 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
MISP 60528 Pneumococcal Vaccination
NCT04845945 ·Status: TERMINATED
-
Immunological Memory Against Pneumococcus Induced by 3 Infant PCV 13 Vaccination Schedules
NCT03405805 ·Status: UNKNOWN
-
Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
NCT06975878 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study Evaluating Prevenar Immunogenicity in High Risk Children
NCT00581620 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Pneumococcal Vaccine Formulations in Young Adults
NCT00707798 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults
NCT01767402 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine
NCT00853749 ·Status: COMPLETED ·Phase: PHASE3
-
Fine Needle aSpiration of Lymph nodEs to Study vAccine-induced Immunity
NCT06202703 ·Status: RECRUITING ·Phase: NA
-
The Effect of Previous Pneumococcal Immunization on the Immune Response of Patients With Severe CKD to Prevnar 13
NCT02370069 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults
NCT06151288 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years
NCT02955160 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49
NCT07284654 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Learn About How a New Pneumococcal Vaccine Works in Children
NCT06531538 ·Status: COMPLETED ·Phase: PHASE2